New Project To Sequence Genes Of Amazon Biodiversity, Enforce Benefit Sharing, Announced At Davos 24/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment A new partnership announced at the World Economic Forum this week plans to sequence the genome of all biodiversity in the Amazon basin and make sure that benefits from the commercialisation of products derived from this mapping are fairly and equitably shared.
Antimicrobial Benchmark For Industry Launched In Davos 23/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Across the Alps from this week’s World Health Organization Executive Board meeting, the first ever antimicrobial resistance benchmark was launched today at the World Economic Forum annual meeting in Davos.
Three New Draft Proposals At WHO: Shortages, Snakebite, Assistive Technology 23/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment Three new draft proposals at the World Health Organization Executive Board this week underline the importance of access and affordability, whether it is vaccines and medicines, including antivenoms, or assistive technology. The draft resolutions call on member states as well as the WHO secretariat to urgently take action to facilitate access to products and technologies at affordable prices.
WTO, WHO, WIPO Symposium To Look At Innovative Technologies And UN SDGs 22/01/2018 by William New, Intellectual Property Watch Leave a Comment Three major international organisations in Geneva dealing with health, trade and intellectual property rights will come together next month to look at how innovative technologies can help to achieve the UN Sustainable Development Goals related to health.
New WHO Director Calls On Board To Join In “Intensive” Period Of Change 22/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment All human beings should receive the health services they need without suffering financial hardship, such is the definition of universal health coverage, a key point of discussion at the World Health Organization Executive Board meeting this week. New WHO Director General Tedros Adhanom Ghebreyesus (Dr Tedros) opened the event by presenting his vision for the future, and the collective work to accomplish necessary changes to the UN health agency. The European Union and United States warned against politicisation of the WHO.
Antimicrobial Resistance The “Scariest” Public Health Issue, Needs Financial R&D Incentives, Industry Says 19/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment On the eve of the annual January World Health Organization Executive Board meeting, an alliance of pharmaceutical industries launched its first report on efforts made to curb antimicrobial resistance. The alliance also organised a conference on the report and on challenges of antimicrobial resistance, in particular the need for research and development incentives so that the industry can continue its efforts sustainably. Some light was also shed on the need to support access to diagnostics, and lower their prices.
Over USD10 Billion Estimated To Implement 5-Year WHO Draft Programme Of Work 18/01/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Health Organization released a financial estimate for its draft thirteenth general programme of work 2019-2023 on 15 January, after member states asked last autumn how that draft programme was to be financed.
Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 by Intellectual Property Watch 1 Comment An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.
Heads Of State At Davos’ Door: Trump, Modi, Macron, May 17/01/2018 by Catherine Saez, Intellectual Property Watch 1 Comment The World Economic Forum is meeting next week in Davos, with Indian Prime Minister Narenda Modi opening the forum, and US President Donald Trump closing it. One of the focuses of the annual meeting will be on finding ways to reaffirm international cooperation on common challenges, such as the environment and the global economy.
New Local Pharmaceutical Plant Expected To Enhance Access To Drugs In Kenya 12/01/2018 by Justus Wanzala for Intellectual Property Watch Leave a Comment Kenya’s pharmaceutical products manufacturing sector is hopeful it will experience significant growth after the Square Pharmaceuticals ltd (SPL) of Bangladesh commissioned a US$ 75 million plant in the East African nation this week. [A reminder: this story, like all of our stories, is completely free for almost every developing country in the world. Just sign up for a free password here!]
